Savers Value Village (SVV) Officer Executes Option Exercise and 10b5-1 Sale
Rhea-AI Filing Summary
Insider transactions by Melinda L. Geisser at Savers Value Village, Inc. (SVV). On 09/26/2025 the reporting person exercised options and sold shares under a pre-existing plan. She exercised options to acquire 20,000 shares at an exercise price of $1.41 per share, and on the same date sold 20,000 common shares pursuant to a 10b5-1 plan for a weighted-average sale price of $13.6923 per share (sales executed in a range of $13.48–$13.87). After these transactions the Form 4 reports 488,373 shares underlying previously granted options as beneficially owned (direct).
The Form 4 notes the exercised options were from the 2019 Management Incentive Plan, with the June 12, 2019 grant fully vested by March 28, 2024, and describes the composition of remaining options as ~22% time‑based and ~78% performance‑based.
Positive
- Exercise and sale disclosed transparently, including exercise price ($1.41) and weighted average sale price ($13.6923)
- Sale executed under a documented 10b5-1 plan, indicating pre-arranged trading
- Large remaining option position disclosed (488,373 shares underlying options) with vesting composition described
Negative
- Officer sold 20,000 shares, which reduces her immediately held common stock by that amount
- Majority of remaining options are performance‑based (approximately 78%), tying future ownership to performance conditions
Insights
TL;DR: Officer exercised options for 20,000 shares and sold 20,000 shares under a 10b5-1 plan; substantial option holdings remain.
The officer executed an option exercise at $1.41 and contemporaneously sold the same number of shares under a 10b5-1 plan at a weighted average of $13.6923, realizing the spread between exercise price and sale proceeds on the executed lots. The filing confirms that the June 12, 2019 option grant is fully vested and that a large majority of remaining options are performance‑based, which may affect future dilution depending on whether performance conditions are met. All statements are drawn from the Form 4 text.
TL;DR: Transactions follow standard insider exercise/sale procedures and were executed pursuant to an established 10b5-1 plan.
The sale was executed under a 10b5-1 trading plan adopted March 10, 2025, as disclosed. The filing identifies the reporting person as Chief People Services Officer and shows proper disclosure of exercise, sale, vesting schedule, and the nature of remaining options (time‑based vs performance‑based). The Form 4 is procedural in nature and contains standard explanatory remarks without additional corporate governance exceptions noted.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option (Right to Purchase) | 20,000 | $1.41 | $28K |
| Exercise | Common Stock | 20,000 | $1.41 | $28K |
| Sale | Common Stock | 20,000 | $13.6923 | $274K |
Footnotes (1)
- The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 10, 2025. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $13.48 to $13.87. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024. Approximately 22% represents time-based options which vested in substantially equal annual installments over 5 years starting March 28, 2020 and approximately 78% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.
